Dextenza 0.4mg intracanalicular Insert

DRUG2 trials

Sponsors

The Eye Centers of Racine and Kenosha, Cathleen McCabe MD

Conditions

CataractDry Eye Syndromes

Phase 4

ACCURATE Study for Subjects With Dry Eyes

CompletedNCT04237012

The Eye Centers of Racine and KenoshaDry Eye Syndromes

Start: 2019-12-16End: 2021-12-30Updated: 2024-11-29

Clinical Investigation of the Dextenza 0.4mg Intracanalicular Insert Delivery System Used in Cataract Surgery

TerminatedNCT04687800

Cathleen McCabe MDCataract

Start: 2020-12-01End: 2022-10-24Updated: 2022-11-10